диссертации / 35
.pdfMetab.− 2003− Vol. 285(4). − P 906-16.
125.Khovidhunkit, W. The pathogenesis of atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host / W. Khovidhunkit, M.S. Kim, R..A. Memon et al. // J. Lipid Res. – 2004. – Vol. 45. – P. 1169-1196.
126.Kim, F. TNFinhibits flow and insulin signaling leading to NO production in aortic endothelial cells / F. Kim, B. Gallis, M. Corson // American Journal of Physiology and Cell Physiology. − 2001.−
Vol. 280. − P.1057 - 1065.
127.Kirwan, J.P. TNFis a predictor of insulin resistance in human pregnancy / J.P. Kirwan, Hauguel-De Mouzon et al. // Diabetes.− 2002.− Vol. 51.− P 2207 - 2213.
128.Kirwan, J.P. Human aging is associated with altered TNFproduction during hyperglycemia and hyperinsulinemia / J.P. Kirwan, S. Krishnan et al. // American Journal of Physiology, Endocrinology and Metabolism. −2001.− Vol. 281, Issue 6, P.11371143.
129.Koffler, S. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation / S Koffler, T. Nickel, M.Weis // Clin Sci (Lond).− 2005.− Vol.108 (3).− P. 205–13.
130.Kralisch, S. Isoproterenol, TNF-alpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes / S. Kralisch, J. Klein, U. Lossner et al. // M. Mol. Cell. Endocrinol.− 2005.− Vol. 240.− P 43–49
131.Kaput J. Application of nutrigenomic concepts to Type 2 diabete melli-tus./ Kaput J, Noble J, Hatipoglu B. // Nutr Metab Cardiovasc Dis. 2007.- №17 P.89-103.
132.Kubaszek, A. Promoter Polymorphisms of the TNF- (G-308A) and IL-6 (C-174G) Genes Predict the Conversion From Impaired
121
Glucose Tolerance to Type 2 Diabetes. The Finnish Diabetes Prevention Study / A. Kubaszek., J. Pihlajamäki, V. Komarovski et al // Diabetes.− 2003 − Vol. 52. − P. 1872-1876.
133.Lakka, H.M. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men / H.M. Lakka, D.E. Laaksonen, T.A. Lakka, et al. // JAMA. – 2002. – Vol. 288. – P. 2709-2716
134.Larousse, M. Increased levels atherosclerosis markers in salt sensitive hypertension. / M. Larousse, E. Bragulat, M. Segarra et al. // Am J Hypertension. − 2006.− Vol.19 (1). – P. 87–93.
135.Lawlor, D.A. ABC of obesity: Obesity and vascular disease / D.A. Lawlor, M .Lean, N .Sattar // Brit. Med. J. – 2006. – Vol. 333. – P. 1060-1063.
136.Lee, S.C. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome / S. C. Lee // Metabolism. −2000.− Vol.
49(8). – P. 1021-4.
137.Li, H. Essential hypertension is associated with subclinical inflammation/ H. Li, Y.C Gong, D.L.Zhu // Am J Hypertens.−2004.−
Vol. 22 (2). −P.323.
138.Li, Z. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease / Z. .Li, S. Yang, H.
.Lin, J. Huang et al. // Hepatology. − 2003. – Vol. 37(2). –P.343-50
139.Libby, P. Changing concepts of atherogenesis / P. Libby // J Intern Med .−2000. − Vol.247. ). – P.349-358.
140.Libby, P. Inflammation and atherosclerosis / P. Libby, P. Ridker, A. Maseri // Circulation.− 2002. − Vol.105. – P.1135—1147.
141.Lindblad, U. Metabolic syndrome and ischemic heart disease in elderly men and women / U. Lindblad, R. Langer et al. // Amer. J. Epidemiol. – 2001. – Vol.153. – P. 481-489.
122
142.Linsel-Nitschke, P. HDL as a target in the treatment of atherosclerotic cardiovascular disease/ P. Linsel-Nitschkeand, A. R. Tall // Nat. Rev. Drug Discov.− 2005. − Vol. 4. – P.193–205
143.Liou, C.W. Metabolic syndrome and three of its components as risk factors for recurrent ischaemic stroke presenting as large-vessel infarction / C.W. Liou et al. // European Journal of Neurology.− 2008.− August,Vol.15, Issue 8.− P.802-809.
144.Litwin, S.E. Which Measures of Obesity Best Predict Cardiovascular Risk? / S.E. Litwin // J Am Coll Cardiol.− 2008.− Vol.52.− P.616— 619.
145.Liu, L. S. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor / L.S.Liu, M. Spelleken, K. Rohring, H. Hauner, J. Eckel // Diabetes.− 1998.− Vol.47.− P.515–522
146.Lopez-Bermejo, A. Adiponectin, hepatocellular dysfunction and insulin sensitivity / A. Lopez-Bermejo, P. Botas-Cervero et al. // Clin Endocrinol (Oxf). −2004.− Vol.60(2). −P.256-63.
147.Lorenzo, C. The National Cholesterol Education Program – Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes / C. Lorenzo, K. Williams, K.J. Hunt, S.M. Haffner // Diabetes Care.− 2007. – Vol. 30(1).− P.8–13.
148.Magyar, MT. Early-onset carotid atherosclerosis is associated with increased intima-media thikness and elevated serum levels of inflammatory markers/ M.T. Magyar, Z. Szikszai, J. Balla et al. //Stroke. − 2003. − Vol.34.− P.58–63.
149.Mancia, G. SMOOTH investigators. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study / G. Mancia, G.
123
Parati, C. Borghi et al. // Hypertens.−2006.− Vol.24.− P.837–843.
150.Mancia, G. Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni(PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis / G. Mancia, M. Bombelli,
G. Corrao et al. // Hypertension.− 2007.− Vol.49.− P.40–47.
151.Mannucci, E. How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study / E. Mannucci, M. Monami, C.M. Rotell //Nutr Metab Cardiovasc Dis.−
2007.− P.24.
152.Masaki, T. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice / T. Masaki, S.Chiba et al. // Hepatology. −2004.− Vol 40(1).− P.177-84
153.Maseri, A. Inflammation in acute coronary syndromes / A. Maseri,
D.Cianflone. // Eur. Heart J. – 2002. – Vol. 4. (Suppl. B). – P. 8-13
154.Mattsson, N. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study / N. Mattsson,
T.Ronnemaa, M. Juonala et al. // J Intern Med.–2007. – Vol.26. №
2.– P.159-169
155.Meigs, J.B. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes. The Framingham Offspring Study / J.B. Meigs, M.G. Larson, C.S. Fox et al. // Diabetes Care. – 2007. – Vol. 30.№10. – P. 2529-2535.
156.Meigs, J.B. Epidemiology of the insulin resistance syndrome / J.B. Meigs // Curr.Diab. Rep.− 2003.− Vol.3(1).− P.73–79
157.Meldrum, D. R. Tumor necrosis factor in the heart / D. R. Meldrum // Amer. J. Physiol. Regul. Integr. Comp. Physoil. −1998.−
Vol.274.№3. − P.R577–R595
158.Morabia, A. The Obesity Epidemic as Harbinger of a Metabolic Disorder Epidemic: Trends in Overweight, hypercholesterolemia, and Diabetes treatment in Geneva, Switzerland, 1993–2003 / A.
124
Morabia, M.C. Costanza // Am J Public Health – 2005. – Vol. 95. –
P.632–635.
159.Ross, R. Atherosclerosis–an inflammatory disease / R. Ross // N. Engl. J. Med.– 1999.– Vol.340.− P.115–126
160.Muratori, I. Relationship between endothelial dysfunction, intima media thickness hypertension and other cardiovascular risk factors in asymptomatic subjects / I. Muratori, E. Corrado, S. Di Chiara et al. // Am J Hypertension.− 2005.− Vol.18.− P.160A.
161.Narkiewicz, K. Obesity and hypertension – the issue is more complex than we thought / K. Narkiewicz // Nephrol. Dial. Transplant. – 2006. – Vol. 21 (2). – P. 264−267.
162.Ninomiya, T. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population. The Hisayama Study / T. Ninomiya, M. Kubo, Y. Doi et al. // Stroke. – 2007. – Vol. 38. – P. 2063−2070.
163.Oh, D.K. Adiponectin in health and disease / D.K. Oh, T. Ciaraldi, R.R. Henry // Diabetes Obes Metab. – 2007. – Vol.9.− P.282-9.
164. .Ohashi, R. Reverse cholesterol transport and cholesterol efflux in
atherosclerosis / R. Ohashi, H. Mu, X. Wang, Q. Yao, C. Chen // Q.
J. Med. −2005.− Vol. 98.− P.845–856.
165.Paquot, N. Adipocytokines: link between obesity, type 2 diabetes and atherosclerosis / N. Paquot, L. Tappy // Rev Med Liege. – 2005.
−Vol. 60(5–6). − P.369–73.
166.Lorenzo, C. The National Cholesterol Education Program – Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes / C. Lorenzo et al. // Diabetes Care.– 2007.– Vol.30(1). −P.8–13.
167.Pausova, Z. Role of tumor necrosis factor-a gene locus in obesity and obesity-associated hypertension in French Canadians / Z. Pausova,
125
B. Deslauriers, D. Gauder et al. // Hypertension. – 2000. – Vol. 36. –
P. 14-19.
168.Pearson, T.A. Wayne Alexander R et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association / T.A. Pearson, G.A. Mensah et al. //Circulation. –2003. – Vol.107:– P.499–511.
169.Peraldi, P. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase / P. Peraldi, G. S. Hotamisligil et al. // J. Biol. Chem.–1996. – Vol.271. – P. 13018–13022
170.Pereira, T.V. Effect of the G-308A polymorphism of tumor necrosis factor alpha gene on the risk of ischemic heartdisease and ischemic stroke: a meta-analysis / T.V. Pereira, M. Rudnicki, R.F Franco et al. // Am Heart J.– 2007.– Vol. 153, −P. 821–830.
171.Perticone, F. Inflammation mediates the link between endothelial dysfunction and mild to moderate renal insufficiency in essential hypertension / F. Perticone, R. Maio, G. Tripepi et al // J Hypertension. – 2005. – Vol. 23 (2). − P.178.
172.Philip, A. Kern. Potential Role of TNF and Lipoprotein Lipase as Candidate Genes for Obesity / Kern. A. Philip // Journal of nutrition.
–1997. – Vol. 127(1). −P.917S.
173.Pihlajamäki, J. The Effect of the -308A Allele of the TNFGene on Insulin Action Is Dependent on Obesity / J. Pihlajamäk, M. Ylinen et al // Obesity Research. – 2003. – Vol.11. − P.912 – 917.
174.Plomgaard, P. TNF-alpha, but not IL-6, stimulates plasminogen activator inhibitor-1 expression in human subcutaneous adipose tissue/ P. Plomgaard, P. Keller et al. // J Appl Physiol. – 2005. – Vol. 98(6). −P.2019 – 23.
126
175.Popa, C. Тhe role of TNF-а in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk / C. Popa, M.G. Netea et al. // J. Lipid Res. – 2007. – Vol. 48. – Р.751−762.
176.Pajvani, U.B.Adiponectin: systemic contributor to insulin sensitivity / U B. Pajvani, P.E. Scherer // Curr Diab Rep.− 2003. − Vol. 3. – Р.
207−213.
177.Porter, M.H. Effects of TNF-u on glucose metabolism and lipolysis in adipose tissue and isolated fat-cell preparations / M.H. Porter, A. Cuthins, J.B. Fine et al. // J Clin Med. –2002.− Vol.139.− P.140–46.
178.Rahmouni, K. Obesity-associated hypertension / K. Rahmouni, M.L. Correia, W.G. Haynes, A.L. Mark // Hypertension. – 2005. – Vol.
45.– P. 9-17.
179.Recasens, M. Obesity and inflammation / M. Recasens, W. Ricart, J.M. Fernandez-Real // Rev Med Univ Navarra. − 2004. − Vol. 48(2). − P.49–54.
180.Regitz-Zagrosek, V. Gender differences in the metabolic syndrome and their role for cardiovascular disease / V. Regitz-Zagrosek, E. Lehmkuhl, M.O. Weickert // Clin Res Cardiol.− 2006.− Vol.95(3). − P.136 –47
181.Ridker, P.M. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women / P.M. Ridker, C.H. Hennekens et al. // Engl. J. Med.− 2000.− Vol.342. − P.836–
182.Ryden, M. Mapping of early signaling events in tumor necrosis factor-alpha -mediated lipolysis in human fat cells / M. Ryden, A. Dicker et al. // J. Biol. Chem. − 2002. − Vol. 277. − P. 1085 – 1091.
183.Ryden, M. Targets for TNF-alpha-induced lipolysis in human adipocytes / M. Ryden, A. Dicker et al. // Biochem. Biophys. Res. Commun. − 2004. − Vol.318. − P.168 – 175
184.Schilinger M, Exner M, Mlekusch W et al. Inflammation and carotid
127
arteryrisk for atherosclerosis study (ICARAS) / M. Schilinger, M. Exner, W. Mlekusch et al. // Circulation. − 2005. − Vol.111. − P.2203–9.
185.Schnyder-Candrian, S. Hepatic steatosis in the absence of tumor necrosis factor in mice / S. Schnyder-Candrian, J. Czarniecki et al. // Cytokine.− 2005 − Vol. 32(6). − P.287 − 95.
186.Shepherd, P.R. Phosphoinositide-3-kinase: the key switch mechanism in insulin signaling / P.R. Shepherd, D.J. Withers, K. Siddle // Biochemical Journal. − 1998. − Vol.333.− P.471.–.490.
187.Shibata, M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middleaged Japanese men / M.Shibata, Y. Kihara et al. // Diabetes Care.− 2007.− Vol.30(11).− P.2940 – 4.
188.Sinisalo, J. Relation of inflammation to vascular function in patients with coronary heart disease / J Sinisalo, J Paronen, KJ Matilla // Atherosclerosis. − 2000. − Vol.149 (2).− P.403.–.11.
189.Sironi, A.M. Visceral fat in hypertension: influence on insulin resistance and beta-cell function / A.M Sironi, A. Gastaldelli, A. Mari et al. // Hypertension. – 2004. – Vol. 44. – P. 127 − 133.
190.Siwik, D.A. Interleukin-1ß and tumor necrosis factor-a decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fi broblasts in vitro / D.A. Siwik, D.L.F. Chang, W.S. Colluci // Circulat. Res.− 2000.− Vol. 86. – P. 1259.
191.Skoog, T. Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men / T. Skoog, W. Dichtl, S. Boquist, C. Skoglund-Andersson et al. // Eur. Heart J. − 2002. − Vol. 23. − P.376 – 383.
192.Sowers, J.R. Hyperinsulinemia, insulin resistance and hyperglycemia: contributing factors in pathogenesis of hypertension and atherosclerosis / J.R. Sowers, P.R. Standley, J.L. Ram et al. // Am. J. Hypertens. – 1993. − Vol. 6. − P.260–270.
128
193.Staiger, H. Adipocytokines: fat-derived humoral mediators of metabolic homeostasis / H Staiger, H.U Haring // Exp. Clin. Endocrinol Diabetes. − 2005. − Vol. 113(2). − P.67 – 79
194.Stenvinkel, P. Endotelial dysfunction and inflammationis there link? / P. Stenvinkel // Nephrol Dial Transplant. – 2001. − Vol. 16. − P.1968 – 71.
195.Stern, M.P., Bartley M., Duggirala R., Bradshaw B. Birth weight and the metabolic syndrome: thrifty phenotype or thrifty genotype? / M.P. Stern, M. Bartley, R. Duggirala, B. Bradshaw // Diabetes and Metabolic Researches Review. − 2000. − Vol.16. − P.88 – 93.
196.Sy, RG. Metabolic syndrome in Asia: time for action / R.G. Sy // MesS Insights. – 2006. − Vol. 94. − P.– 7.
197.Suganami, T. Role of the toll-like receptor 4/NF-kB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages / T. Suganami, K. TanimotoKoyama, J. Nishida et al. // Arterioscler. Thromb. Vasc. Biol. – 2007. – Vol. 27. – P. 84 − 93.
198.Sun, M. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction / M. Sun, F. Dawood, W.H. Wen et al.//Circulation. – 2004. − Vol.110. − P.3221 – 8
199.Svenungsson, E. Elevated triglycerides and low levels of highdensity lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus / E. Svenungsson, I. Gunnarsson, G. Z. Fei, I. E. Lundberg et al. // Arthritis Rheum. − 2003. − Vol.48. − P.2533 – 2540
200.Targher, G.Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? / G. Targher, F. Marra, G. Marchesini // Diabetologia. – 2008.−. Vol. 51(11):1.−.
129
P.947 − 53
201.Thomas, F. Cardiovascular mortality in overweight subjects. The key role of associated risk factors / F. Thomas, K. Bea, B. Pannier et al. // Hypertension. – 2005. – Vol. 46. – P. 654 − 663.
202.Tilg, H. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance / H. Tilg, G.S. Hotamisligil // Gastroenterology. – 2006 − Vol. 131(3). − P.934 − 45.
203.Tillin, T. Metabolic syndrome and coronary heart disease in South Asians, African & Caribbeans and white Europeans: a UK population & based cross & sectional study / T. Tillin, N. Forouhi, D.G. Johnston et al. // Diabetologia. – 2005. − Vol.48. − P.649 – 656.
204.Togashi, N. Effect of TNF-a –Converting Enzyme Inhibitor on Insulin Resistance in Fructose-Fed Rats / N. Togashi, N. Ura, K. Higashiura et al. // Hypertension. − 2002. − Vol.39. − P.578 − 580.
205.Tulyakova, G. Association of the – (G→A) polymorphim of tumor necrosis factor α with myocardial infarction and sudden cardiac death / G. Tulyakova, T. Nasibullin , A. Salmanov et al. // Balkan J. Med. Genet. −2005. − Vol. 8. № 3–4. − P.31 – 35
206.Verstrepen, L. "TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme" / L. Verstrepen, T. Bekaert, T.L. Chau et al. // Cell Mol Life Sci. − 2008. − В. 19. − Т. 65. −. P 2964 − 2978.
207.Vuguin, P.Hepatic insulin resistance precedes the development of diabetes in a model of intrauterine growth retardation / P. Vuguin, E. Raab et al. // Diabetes. – 2004. − Vol. 53(10). − P.2617 − 22.
208.Wang, T.J. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham heart study / T J. Wang, Nam. Byung-Ho, P.V.F. Wilson et al. // Arteriosclerosis,
130